key: cord-0332391-72r6th1x
authors: Tomberg, Kärt; Antunes, Liliana; Pan, YangYang; Hepkema, Jacob; Garyfallos, Dimitrios A.; Mahfouz, Ahmed; Bradley, Allan
title: Intronization enhances expression of S-protein and other transgenes challenged by cryptic splicing
date: 2021-09-15
journal: bioRxiv
DOI: 10.1101/2021.09.15.460454
sha: 83523083f539f260ceaab6f1ba194c37235d3201
doc_id: 332391
cord_uid: 72r6th1x

The natural habitat of SARS-CoV-2 is the cytoplasm of a mammalian cell where it replicates its genome and expresses its proteins. While SARS-CoV-2 genes and hence its codons are presumably well optimized for mammalian protein translation, they have not been sequence optimized for nuclear expression. The cDNA of the Spike protein harbors over a hundred predicted splice sites and produces mostly aberrant mRNA transcripts when expressed in the nucleus. While different codon optimization strategies increase the proportion of full-length mRNA, they do not directly address the underlying splicing issue with commonly detected cryptic splicing events hindering the full expression potential. Similar splicing characteristics were also observed in other transgenes. By inserting multiple short introns throughout different transgenes, significant improvement in expression was achieved, including >7-fold increase for Spike transgene. Provision of a more natural genomic landscape offers a novel way to achieve multi-fold improvement in transgene expression.

Efficient expression of exogenous genes to produce recombinant therapeutic human proteins and immunogens from DNA expression vectors in mammalian cells in vitro and in vivo is of fundamental importance to the biopharmaceutical industry. Poor expression has been reported for many recombinant proteins and for both SARS-CoV and SARS-CoV-2 Spike (S) proteins when using non-optimized wildtype complementary DNA (cDNA) sequences (1, 2) . In many cases expression of exogenous proteins has been iteratively improved by increasing translational efficiency via codon optimization of the protein coding sequence (CDS) and overall mRNA levels can be enhanced by promoter choice and addition of cis-acting modules like 5'UTR introns.

Codon optimization was first applied over 40 years ago, before the cDNA sequence of the desired peptide hormone was even known to the authors (3) . It is now routinely used for applications in bioproduction as well as in vivo nuclear therapeutic applications (4, 5) .

Although codon optimization is now a standard tool used in recombinant protein expression systems to increase expression, potential downsides affecting protein structure and function have also been raised (6, 7) .

Given that the number of mRNA transcripts per cell will influence protein levels emphasis has been placed on increasing transgene copy number as this can overcome poor expression and quality (full-length) transcripts. Convenience of packaging and delivery by viral vector systems and the ability to achieve higher copy numbers of smaller constructs has led to the almost universal use of cDNAs by the biopharmaceutical industry even though the importance of intronic sequences for eukaryotic gene expression was shown over 40 years ago (8) . While 97% of endogenous protein coding genes in humans contain introns and intron/exon boundaries are extremely highly conserved across species, non-intron containing cDNAs are almost invariably used as transgenes. Numerous aspects of gene expression are affected by introns including initial transcription of the gene, rate of transcription, polyadenylation, nuclear export, RNA editing, translational efficiency, and mRNA decay (9, 10) .

Examples of 5'UTR intron mediated expression improvements have led to inclusion of 5'UTR intron in many transgenes' designs (11) . Benefits from adding multiple introns into transgenes are however controversial, while some studies describe benefits achieved with constructs containing multiple endogenous introns (12) and heterologous introns (13) (14) (15) other studies report no added benefit achieved by more than a single intron (16) .

Expressing genetic sequences in a novel context, such as genes from a cytoplasmic RNA virus that never enters the nucleus as a cDNA is inevitably challenged by cryptic splicing, a situation where a cryptic intron is efficiently recognized and excised within the intended CDS. This can lead to no or low expression of the full-length protein as well as production of truncated and out-of-frame protein fragments (17, 18) . Cryptic splice sites (SS) that contain a consensus motif sequence in addition to the canonical splice donor (SD) dinucleotide ' GT' or the canonical splice acceptor (SA) dinucleotide 'AG' within the CDS can be removed by codon optimization. In situations where desired protein expression is observed from a codon-optimized construct, alternative splicing events that lead to aberrant mRNAs, protein fragments and out of frame products may only be discovered by in-depth analysis as recently reported for SARS-CoV-2 S protein sequences used in some COVID-19 vaccines (19, 20) .

Here, we report extensive cryptic splicing events within both wildtype and various codonoptimized SARS-CoV-2 S protein sequences as well as other transgenes. While removing canonical cryptic SS alleviates the repetitive splicing outcomes facilitated by the presence of conserved SS, it does not resolve the issue. We show that by inserting multiple introns protein expression of a number of transgenes has been enhanced by up to 9-fold, opening 5 an opportunity for improving transgene expression and protein quality in bioproduction as well as in DNA vaccines.

Poor expression of full-length S protein from the non-optimized DNA sequences SARS-CoV-2 CDS are conventionally codon-optimized for expression as DNA transgenes.

Wildtype (P1, P2) and codon-optimized (P13) constructs for S protein were compared with respect to production of protein ( Figure 1 ). Anti-S protein or FLAG-tag antibodies failed to detect expression from either wildtype construct while the codon-optimized version yielded both full length and variety of smaller products ( Figure 1B ). Surface staining was detected at a low level from P2 while the codon-optimized construct yielded detectable S protein expression in nearly 60% of cells ( Figure 1C ). Changes to the 5' and 3' expression elements around the transgene CDS did not improve wildtype S expression (P3-P9, Sup Figure 1 ).

However, when the wildtype S protein CDS was transfected as a mRNA, protein expression was detected in 9% of cells confirming the coding sequence was functional. Transfection of mRNA from the P13 codon-optimized construct yielded similar numbers of expressing cells compared with the DNA counterpart (59% vs 53%, Figure 1D ).

To understand the discrepancy in expression between wildtype S DNA and mRNA as templates, an RT-PCR spanning from the 5'UTR to 3'UTR was performed on cells transfected with P1. A predominant 280 bp PCR product was detected while the expected 4011 bp product was not observed (Figure 2A, 2C ). Sequencing identified this as an alternatively spliced mRNA transcript generated using a SD site upstream of the start codon (SD-15) and a SA site at 3' end of the S protein CDS (SA3716). A similar outcome, albeit using a different SD site within the Human T-cell Leukemia Virus (HTLV) 5'UTR, was observed for P2 (Sup Figure 2 ). These observations reflect the biology of SARS-CoV-2 whose genome as a cytoplasmic RNA virus has not evolved to support expression from a nuclear DNA template. The virus's S protein sequence alone harbors 111 SS predicted by ASSP software (Sup Table 1 ) (21) .

In an attempt to resolve the cryptic splicing outcome, three constructs eliminating both observed and predicted SS were generated while retaining identical amino acid sequence.

P10 has SD-15 site removed, P11 has both SD-15 and SA3716 removed while P12 has 108 out of the 111 predicted SS removed (Sup Table 1 , Figure 2B ). These edits failed to improve full length S protein expression ( Figure 2C -D), but did change the underlying cryptic splicing outcomes from a single preferred event using available canonical SS to a spread of random events stemming from non-canonical SS in P12 ( Figure 2C , Sup Figure 3 ).

Cryptic splicing validated with Nanopore direct cDNA sequencing To efficiently detect cryptic splicing events, Nanopore cDNA direct sequencing was carried out on four biological replicates from cells transfected with P1 plasmid and two different transcript specific primers for cDNA synthesis (R and R2, Figure 3A ). The distribution of splicing events had some variation. The primer positioned at the most 3' end of the construct (R2) captured more diverse cryptic splicing compared to one positioned more 5', as expected ( Figure 3B ). The most frequent splicing outcome was consistent with the use of SD-15 and SA3716 sites ( Figure 3B -C).

Codon optimization impacts cryptic splicing frequency but does not abolish it While codon-optimized S transgenes improve S protein expression, this change cannot be solely explained by enhanced protein translation as the wildtype codon sequence in the context of live SARS-CoV-2 viral infection results in ample expression of S protein.

Furthermore, as we have shown, removal of canonical SS from the wildtype sequence simply uncovers non-canonical cryptic SS.

Four different codon-optimized S protein sequences P13-P16 with different optimization approaches (Sup Table 2 ) were assessed to investigate this further ( Figure 4A ). All constructs resulted in full size S protein expression and surface staining ( Figure 4B-4C) .

Nevertheless, an RT-PCR analysis captured multiple transcripts in addition to the anticipated full-size 4kb product ( Figure 4D ) and various cryptically spliced events were identified for all constructs (Sup Figure 4 ). Two types of splicing outcomes were observed: random unique events using various canonical and non-canonical SS (P13, P16) or repetitive splicing outcomes stemming from the same selected canonical SS (P14, P15).

Transcripts from P13 and P15 were investigated further by Nanopore cDNA direct sequencing using two different 3' primers as before ( Figure 5A ). The overall proportion of correct full-length reads was much higher for P13 (P13-1: 81%, P13-2: 53%) compared to P15 (P15-1: 23%, P15-2: 3%), consistent with the S protein expression levels. Splicing events from P13 were randomly distributed across the sequence with no strong SS preference for SD (orange bars) or SA (grey bars) sites, compared to the SD/SA of the 5'UTR intron ( Figure 5C ). These SS usage characteristics remained similar also when looking at all the mapped reads as well as when a construct without a 5'UTR intron was used (P17, Sup Figure 5 ). P15 splicing events repeatedly relied on the same few SS (Sup Table 1 ) within the sequence observed both in the full length read population ( Figure 5D ) as well as when all reads were considered (Sup Figure 6A ).

While both P13 and P15 codon optimization strategies resulted in a similar number of predicted SS within the S protein sequence (78 v 86), the prediction scores across the SS were significantly higher for P15 (t-test: p<0.0005, Sup Table 1 ). Nevertheless, not all the frequently observed SS in P15 had a high prediction score. Preferred sites included SS originally present in wildtype S sequence, slightly modified wildtype S sequence SS as well as novel sites introduced by the codon optimization process (Sup Figure 6B ). Different combinations between the same set of SD/SA sites were observed, but the distribution was not random and often the preferred combination for a SD site was with its closest SA site ( Figure 5D , Sup Figure 6C ).

The presence of multiple canonical SS within P15 seems to drive the high level of observed cryptic splicing outcomes whereas in P13 the cryptic splicing events are less frequent and more opportunistic. When looking at all the observed splice events within the S protein sequence, no obvious location patterns emergeevents can start and end across the entire span of the sequence ( Figure 6A , Sup Figure 7A ). While the majority of the splicing events relied on canonical SD ('GT') and SA ('AG') sequences or at least one of the two (yellow, Figure 6B ), many events also displayed the use of non-canonical sequences ( Figure 6C Although the CanSino S protein sequence had the lowest average cryptic SS prediction score (4.3) it still contained two predicted 'constitutive' sites compared to 7-8 present in other codon-optimized S protein sequences (Sup Table 1 ).

To assess splicing in other transgene settings, a codon-optimized viral sequence from the S protein of ChAdOx1 MERS vaccine candidate (P20) and a non-optimized human cDNA sequence for ACE2 protein (P21) were tested. Both of these constructs exhibited cryptic splicing (Sup Figure 9B -C). Similar cryptic splicing events were found in 8% of the published Nanopore RNA direct sequencing data from a cell line transfected with a construct designed to express a human cDNA encoding the ALKBH5 protein (23). The majority of the cryptic events stemmed from a few preferred canonical SS present within the transgene sequence (Sup Figure 10 ). All these data support the conclusion that observed cryptic splicing events are widespread and can be present in different transgenes regardless of the origin and optimization status of the CDS.

Removal of canonical SS within transgene sequences can clearly alleviate repetitive cryptic splicing outcomes and improve transgene expression, exemplified in the performance difference between P13 and P15. However, this approach is insufficient in resolving the random cryptic splicing that continues despite the lack of optimal SS. This seemingly opportunistic splicing brought our attention to an obvious difference between transgenes and endogenous genesthe exon length.

While transgenes are typically designed as one long exon with an optional small 5' noncoding exon, an average endogenous CDS in the human genome is broken up by more than 10 introns with an average length of coding exons at around 160 bp (24). SARS-CoV-2 S protein CDS is over 20 times longer than the exon length anticipated by the endogenous expression and splicing machinery. The introduction of small intronic sequences with conserved canonical SS at anticipated intervals was hypothesized as a potential solution for shifting random opportunistic splicing towards a controlled splicing outcome. To test this idea, several small endogenous human introns were introduced into various transgene CDS to achieve a more 'natural' gene landscape. where codon optimization allowed creation of such sequence without changes to the protein to further accommodate optimal binding of U1 and reflect the more commonly preferred SA sequence in human genome (26).

To assess the impact of intronization on top of standard codon optimization, the best expressing S protein sequence (P16) was used. An increasing number of introns were added and the 5'UTR intron as well as the 3'FLAG elements were removed (P22-P26, Figure 7A ). Improvements in S protein expression were measured using a pseudotyped virus infection assay. This assay requires formation and function of an S trimer and is expected to more faithfully reflect levels of intact and functional S protein expression. The addition of introns and concomitant decrease of exon length, progressively improved S protein function as the number of introns increased resulting in a > 7-fold improvement for the best sequence (t-test: p<0.0005, Figure 7A ). The maximum number of inserted introns (13 introns, exons ranging from 220-321 bp) was guided by the median (278 bp) and mean (321 bp) lengths of coding exons of TTN and were inserted in the 5'-3' order of appearance within the TTN gene.

In order to assess whether the same principles apply in other transgenes, an increasing number of introns were next introduced to the hACE2 CDS, using some of the endogenous intron locations. While keeping the average exon size similar to TTN, two introns from other human genes (RIF1 and CCNG2) were used here to demonstrate that intron origin is not relevant. Significant improvement in expression (t-test: p<0.005) was observed when 9

introns were introduced to the hACE2 sequence (P27-P30, Figure 7B ).

To explore if further reduction to exon size can be beneficial, we introduced introns into the commonly used fluorophore mCherry. Despite mCherry CDS being only 711 bp long, intronization with 7 introns (exons ranging from 84 bp to 127 bp) increased average expression levels by approximately 9-fold (t-test: p<0.0005, P31-P33, Figure7C). These data demonstrate that intronization benefits expression of both endogenous as well as exogenous sequences. Implementation of this strategy may provide a general solution for managing cryptic splicing events and further improve protein expression from codonoptimized transgenes.

The coding elements of SARS-CoV-2 and other cytoplasmic viruses are optimized through Darwinian selection to serve as efficient templates for protein translation, replication and packaging. These sequences have not been subjected to selective pressures required for nuclear expression. Hence, expression of a SARS-CoV-2 gene CDS from a cDNA template in a nucleus will be inefficient. Potential cryptic SS, undesirable GC content, unintended transcription factor binding sites and other DNA features impacting sequence secondary structure or epigenetic landscape will all impact the performance of the sequence.

To achieve "efficient" expression of a CDS from a cytoplasmic RNA virus from a cDNA template, the rigorous iterative process of evolutionary selection may be substituted by a process of codon optimization. Through this process we adapt the sequence to conform to our understanding of the requirements of nuclear expression, capitalizing on the degenerate codon usage available for most amino acids. In principle the underlying DNA coding sequence can be adjusted by more than 65% without altering the underlying amino acid sequence. As codon usage per se is likely not the primary challenge for mammalian viral sequences which have evolved to use the same translational machinery, it really would be more pertinent to call this process sequence optimization. While codon optimization strategies do not directly target SS, GC content or other possible functional sequences, changing the sequence to the more frequently used codons may tackle these problems indirectly and inadvertently.

Analysis of the S protein wildtype sequence demonstrated that both cryptic SS and suboptimal GC content were critical obstacles for achieving full length RNA expression.

While the wildtype S sequence (P1, P2) had strong preference of SS-usage, removal of these sites without really improving its GC content (P1: 37%, P12: 39%) was not sufficient for the sequence to be recognized as "exonic" by the expression and splicing machinery.

Cryptic splicing events still occurred in constructs where all canonical SS had been removed (P12) but they just became non-repetitive as a result of the use of random non-canonical SS. It is well-known that the exonic regions in humans and other mammals have a higher GC content (27) and inadvertently, the most used codon triplicates tend to end with either a 'C' or a 'G' where possible (Kazusa Codon Usage Database). Swapping most of the codons to the most common or second most common triplet significantly increased S protein sequence GC content (P13: 57%, P14: 55%, P16: 54%, Sup Table 2 ). Distributing codon usage equally between all options also improved GC content (P15: 46%, Sup Table 2 ).

While increasing sequence GC content correlates with improved transcription as well as translation, high translation speed is not always considered optimal (28). In fact, many membrane proteins include less frequently used codons which is assumed to reduce the translation rate to facilitate correct folding (28). While the P15 optimization strategy may have benefitted S protein folding, the lack of attention to SS meant it was the least optimal codon-optimized S protein sequence we investigated.

Recent advances in long-read sequencing technologies such as Oxford Nanopore and PacBio have enabled us to capture splicing events better than ever before. The major advantage of the Nanopore cDNA direct sequencing approach used here was the lack of DNA amplification steps while still being able to enrich the sample with gene specific primers. The main limitation lies in the quantification of the observed events in comparison to the reads without events which can be influenced by size dependency of some of the sample preparation steps as the full-size S protein cDNA is over 4kb long and many of the observed splicing events can be shorter than 200 bp and depleted by many sample preparation methods. Reported here are distributions based on the full length read population alone within each sample, but care should be applied before comparing these frequencies to other datasets with different sample preparation methods, such as the ChAdOx1 Nanopore RNA direct data (Sup Figure 8 ).

Hundreds of randomly spaced splicing events characterized by the cDNA direct sequencing approach for the S protein and similar events seen in other proteins highlight the fact that even when the transgene's CDS is apparently well designed and expression of full-length protein can be detected, the status quo design is just not optimal for RNA expression as transcript heterogeneity will inevitably impact both product levels (yield) and homogeneity.

The impact of this will be dependent on the nature of the product, whether it is expressed in vitro or in vivo. In vitro expression offers opportunities to improve homogeneity by application of purification methods. Two thirds of cryptically spliced RNA molecules would be out-offrame and would not just impact protein yield but any translation in vivo would generate novel peptides with potential immunogenicity. In-frame products are potentially of greater impact. In an in vitro expression system, they may co-purify with the full-length product requiring more complex purification processes to achieve a homogenous product. Proteins like the trimeric S-protein are particularly vulnerable to disruption by in frame fragments as these can be incorporated into, and have dominant negative impact on the complex as exemplified by human germ line mutations in trimeric collagens causing diseases like Osteogenesis Imperfecta (29).

While the benefit of having a 5'UTR intron was identified decades ago (8), frequent introns spaced throughout the gene were not considered as practical or necessary. The genes for many human therapeutic proteins cover large genomic expanses and contain numerous large introns. Such loci are significantly larger than the cloning capacity of vectors used for expression purposes and therefore these have been most conveniently handled as cDNAs.

While in many cases these do express at some level, the benefits that introns bring has been under appreciated compared to the other factors that impact expression such as copy number, promoter strength and integration site. Furthermore, the epigenetic landscape of exons and introns was not well understood, even though intron/exon boundaries are highly conserved in orthologous and paralogues across hundreds of millions of years of evolution.

Regenerating a more 'natural' landscape in transgenes had an immediate impact on protein expression and function. Introns improved expression in the context of sequences that naturally do not harbor introns to begin with (S protein), as well as when inserted into nonendogenous locations (mCherry) or endogenous intron locations with no change to the native exonic sequences (hACE2). The latter highlights how intronization approach can serve as an alternative way of increasing recombinant protein expression without the need to change the natural codon selection in products where codon optimization has been shown to impact protein structure and function.

Intron-exon landscape reengineering not only guides the splicing events towards specific splicing outcomes, but may also play a role in increasing recognition, accessibility and/or recruitment of expression machineryan area that will need further investigation in the future. The multi-fold expression improvement and anticipated reduction in product heterogeneity has wide implications within the medical field alone from recombinant protein production to vaccines and in vivo therapies. Table 1 gives an overview of all the DNA plasmids expressing SARS-CoV-2/MERS Spike and hACE2 protein used in this paper. Full DNA sequences of these plasmids are found at a Flow cytometry assays Cells were harvested 48h post-transfection, using trypsin dissociation. Upon harvesting, cells were washed twice with staining buffer (see Table 2 ). They were then incubated with the appropriate dilution of primary antibody (in staining buffer) for 30 min at the indicated temperature. Cells were washed twice and incubated with secondary antibody (1:500) for 30 min on ice (for non-conjugated primary antibodies). Following another set of two washes, cells were analysed by flow cytometry using Cytoflex (BD Biosciences). Data analysis was performed using FlowJo software (BD Biosciences). S protein expression data is plotted as % of positively stained cells (Figure 1, 4, Sup Fig 1) , while ACE2 and mCherry data is visualized as intensity median value normalized to intronless constructs to highlight the shift in population intensity (Figure 7 ). After blocking with 5% skim milk in TBS-T, incubations with primary and secondary antibodies were carried out as detailed in Table 3 . Staining was developed using 20X

LumiGLO® Reagent and 20X Peroxide reagents according to manufacturer's recommendations (Cell Signaling Technology, #7003). and treated with ezDNase (ThermoFisher). Three independent 1 st strand cDNA synthesis reactions using SuperScript IV reverse transcriptase (ThermoFisher) were carried out using a transcript specific reverse primer (either FLAG_R or 3'UTR_G-polyA _R2, Table 4 ). RNA was degraded using RNase Cocktail Enzyme Mix (ThermoFisher #AM2286). The three samples were next bead purified (AMPure XP beads) using three different volume ratios (1X-2X-4X) to ensure capturing the entire size range of splicing products. 2nd cDNA strand was again synthesized using a transcript specific primer (either 5'UTR_G-intron _F or 5'UTR_CMV _F2, Table 4 ) and Q5 2x master mix (NEB, #M0494). After another round of bead purification, samples were pooled and submitted to Edinburgh Genomics, where they were further processed, barcoded and run on PromethION platform.

Reads from all samples were aligned to the relevant construct templates using minimap2.

Parameters for the different minimap2 alignments can be found here:

https://github.com/jacobhepkema/RNA_deletions. The aligned reads were next investigated for splicing events using an in-house script available at the above repository. Reads for the ALKBH5 experiment were downloaded from SRA accession SRR9646144, and reads for the ChAdOx1 experiment were downloaded from SRA accession SRR13320597. The template used to align the ALKBH5 reads to was constructed manually, by performing in silico Gateway cloning, inserting the ALKBH5 CDS and mRuby3 CDS into the pLIX_403 vector (Addgene plasmid #41395). The linker region between ALKBH5 and mRuby3 was constructed manually by finding the consensus at each position for reads mapping to the end of the ALKBH5 CDS or the start of the mRuby3 CDS, with the requirement that the ALKBH5 CDS and mRuby3 CDS were in-frame. Overview of all the aligned reads, splicing events, and span is available in Sup Table 3 . All data visualization was created using R (basics). Nanopore cDNA direct library preparation and sequencing was carried out by Edinburgh

Genomics.

Conceived A.

B.

P13-1

All splicing events within S protein AAAA  AAAC  AAAG  AAGC  AATA  ACAG  ACCA  ACCT  ACGG  ACTT  AGAG  AGAT  AGCA  AGCT  AGTG  ATAG  CAAC  CAAG  CACA  CACC  CACT  CAGA  CAGG  CATC  CATT  CCAG  CCCA  CCCC  CCGA  CCTA  CCTG  CCTT  CGAA  CGAC  CGAG  CGGA  CGTA  CTAC  CTAG  CTAT  CTCC  CTCG  CTCT  CTGA  CTGG  CTGT  CTTG  CTTT  GAAG  GACT  GAGG  GATC  GCAG  GCCA  GCCT  GCGG  GGAC  GGAG  GGAT  GGTG  GTAA  GTAC  GTAG  GTAT  GTCC  GTCG  GTCT  GTGA  GTGC  GTGG  GTGT  GTTA  GTTC  GTTG  GTTT  TAAG  TACG  TACT  TAGT  TCAC  TCGC  TGAG  TGGG  TGTA  TTAG  TTGA   0 Commercially available wt S protein construct P2 also leads to cryptic splicing events. RT-PCR with primers positioned from 5'UTR to 3'UTR of the P2 construct (F,R) followed by TA-cloning and Sanger sequencing identified cryptically spliced mRNA product (294bp) that uses a canonical SD site within the HTLV 5'UTR (also used by HTLV within native setting) and a SA site available within the wt S protein sequence at position 3716 (same SA site as for P1). TAAC  TAAG  TAAT  TACT  TATA  TCAC  TCAG  TCCC  TCCG  TCGT  TCTG  TGAG  TGCA  TGTG  TTAT  TTCC  TTGG  TTTG   0 

Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS

Guangzhou Enbao Biomedical Technology Co ltd (Cn), assignee. Adenovirus vector vaccine for preventing SARS-CoV-2 infection

Escherichia coli of a chemically synthesized gene for the hormone somatostatin

Optimizing antibody expression: The nuts and bolts

Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines (Basel)

Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies

A critical analysis of codon optimization in human therapeutics

Splicing and the formation of stable RNA

How introns influence and enhance eukaryotic gene expression

How introns enhance gene expression

Overview: engineering transgenic constructs and mice

The role of intron sequences in high level expression from CD45 cDNA constructs

Gleba Yuri (De), inventor; Icon Genetics Gmbh (De), assignee. Rna Virus-derived Plant Expression

High-efficiency genome editing in plants mediated by a Cas9 gene containing multiple introns

Interruption of coding sequences by heterologous introns can enhance the functional expression of recombinant genes

In vivo measurements reveal a single 5'-intron is sufficient to increase protein expression level in Caenorhabditis elegans

Removal of a cryptic intron and subcellular localization of green fluorescent protein are required to mark transgenic Arabidopsis plants brightly

Expression of a human cDNA in moss results in spliced mRNAs and fragmentary protein isoforms

SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription

Characterization and prediction of alternative splice sites

Identification of human short introns

 AAAA  AAAC  AAAG  AAAT  AATA  ACAG  ACCA  ACGC  ACGG  ACTC  AGAG  AGCC  AGGC  ATAG  CAAG  CAAT  CACA  CACC  CAGC  CAGT  CATG  CCAG  CCCA  CCCG  CCGC  CCGG  CCTG  CGAA  CGAG  CGCT  CGGC  CGTG  CTAC  CTAG  CTCG  CTGA  CTTG  GAAG  GCAG  GCCA  GCCC  GCCT  GCGC  GCGG  GCTG  GCTT  GGAG  GGCA  GGCG  GTAA  GTAG  GTAT  GTCA